Skip to content
Novalix logo — Novalix is a premier drug discovery CRO

Novalix

Novalix is a premier drug discovery CRO

Founded 2002 France France 371 employees Corporate Round Total: $2.00M Biotechnology

General Information

Company Name Novalix
Founded Year 2002
Location France France
Employees 371
Industries Biotechnology
Funding Stage Corporate Round
Social

BounceWatch is an independent company data service, not affiliated with Novalix. To contact Novalix, visit novalix.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Novalix compare?

A PDF of Novalix and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Novalix soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Novalix

Novalix is a premier drug discovery CRO providing services to biotech firms and pharmaceutical companies. The company, founded in 2002, emphasizes the significance of exceptional scientific talent and exclusive resources, offering a range of platforms to improve the success rate during pre-clinical stages. Their slogan, "Novalix is a premier drug discovery CRO," reflects their commitment to leveraging high-quality science for superior outcomes. Based in France, the company recently secured a Corporate Round investment on 07 August 2024, with Bruker being the investor. For additional information, interested parties can visit www.novalix.com.

Business keywords: Drug discovery, Biophysical technologies, Outsourcing, SPR technology, X-ray protein crystallography, NMR technologies, Medicinal chemistry, Structural biology, Chemical development, Biologics analysis, Pharmaceutical development, Manufacturing support, Epigenetic targets, Native mass spectrometry, Flow chemistry

Services & Products

Drug discovery
pharmacology
biophysics
chemistry
cosmetics
consulting services
technical services

Target Customers

Biotech firms pharmaceutical companies research and development departments clinical development teams

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Corporate Round Undisclosed 1
Bruker
07 Aug 2024
Venture Round €2.00M 2
Bpifrance, Région Grand Est
15 Dec 2020

Novalix Alternatives & Competitors

View All Alternatives
Novalix vs
Nexo Therapeutics
Nexo Therapeutics United States

We’re driven to translate the most compelling and still undrugged targets in human biology into med...

Series A
19 employees
Biotechnology, Health and Wellness
Novalix vs
Septerna
Septerna United States

Bringing a new era of GPCR medicines to patients with its Native Complex Platform™.

IPO
137 employees
Biotechnology, Pharmaceutical
Novalix vs
CheminPharma
CheminPharma United States

Products & services for the biotech community

4 employees
Biotechnology

FAQ About Novalix

Novalix is a premier drug discovery CRO
Novalix was founded in 2002.
Novalix is headquartered in France.
Novalix operates in Biotechnology. Its work centres on Drug discovery, Biophysical technologies, Outsourcing and SPR technology. Its customers include Biotech firms, pharmaceutical companies and research and development departments.
Novalix has approximately 371 employees.
Novalix has completed 2 funding rounds, raising a total of $2.00M. The latest funding stage is Corporate Round.
Novalix offers: Drug discovery, pharmacology, biophysics, chemistry, cosmetics, consulting services, technical services.
Top alternatives and competitors to Novalix include Nexo Therapeutics, Septerna, CheminPharma, Ventus Therapeutics, Genosco. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Novalix and Nexo Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Novalix, https://bouncewatch.com/company/novalix, updated 7 June 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout